policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
NIH funds development of novel Lyme disease vaccine
The grant is funding the efforts of tick immunobiologist Utpal Pal, PhD, to adapt the rabies vaccination platform to stimulate production of…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
AVMA news
Conference of Research Workers in Animal Diseases – January 20-24, 2023
The Conference of Research Workers in Animal Diseases (CRWAD) held its annual conference from January 20-24 in Chicago. The CRWAD presented awards,…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.